Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
William M Mitchell is Director at Aim Immunotech. OQRO lists 2 transactions filed with the SEC under this name, the latest on Apr 23, 2025, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Aim ImmunotechAIM
2 disclosures · Dec 2024 – Apr 2025 · 1 bought · 1 sold
Apr 11, 2025Bought~$5Kdisclosed Apr 23
DetailsOfficial recordDec 19, 2024Sold~$884disclosed Dec 20
DetailsAs of the latest filing on , William M Mitchell reported holding 521,723 shares of Aim Immunotech (AIM), worth about $75K at the last close of $0 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aim Immunotech AIM | 521,723 | 522K direct | $0 | $75K | Apr 11, 2025 |
Is this William M Mitchell’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
William M Mitchell bought shares on the open market in 2005, 2019 and 2025. Sales in 1 of the 22 years since 2005.
William M Mitchell reported 4 open-market purchases and 1 sale since 2005; purchases in 3 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $5K1×1 trade | — |
| 2024 | — | $8841×1 trade |
| 2019 | $39K1×1 trade | — |
| 2005 | $5.7K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Apr 11, 2025, William M Mitchell reported holding 521,723 shares of Aim Immunotech (AIM). At the last close of $0 on Nov 13, 2026, that is about $75K. This is the stake disclosed in filings, not a net worth.
William M Mitchell bought shares on the open market in 2005, 2019 and 2025. Sales in 1 of the 22 years since 2005.
In SEC filings since 2005: the latest open-market purchase is from 2025; the latest open-market sale is from 2024.
Aim Immunotech (AIM), from 2005 to 2025: 4 purchases and 1 sale.
William M Mitchell reported 4 open-market purchases and 1 sale here, 2005 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
